Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study
Publication Type:
Journal Article
Authors:
M P Curry;
Forns, X.;
Chung, R.T.;
N A Terrault;
R S Brown Jr.;
Fenkel, J.M.;
Gordon, F.;
J G O'Leary;
Kuo, A.;
Schiano, T.;
G.T. Everson;
E R Schiff;
Befeler, A.;
E J Gane;
Saab, S.;
J G McHutchison;
Subramanian, G.M.;
Symonds, W.T.;
Denning, J.;
McNair, L.;
Arterburn, S.;
E. S. Svarovskaia;
Moonka, D.;
N H AfdhalSource:
Gastroenterology, Volume 148, Issue 1, p.100-107 (2015)
Keywords:
Anemia,
Arteries,
Boston,
California,
Carcinoma,
Cities,
Colorado,
complications,
Fatigue,
Florida,
Genotype,
HCV,
Headache,
Health,
hepatitis,
Hepatitis C,
hepatitis C virus,
Infection,
Israel,
Liver,
Liver Transplantation,
Los Angeles,
Massachusetts,
Medicine,
methods,
Michigan,
Missouri,
New York,
New Zealand,
Patients,
Philadelphia,
Recurrence,
Ribavirin,
Rna,
San Francisco,
sofosbuvir,
Spain,
Texas,
Time,
transplantation,
treatment,
Universities
